US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

uniQure N.V. - Ordinary Shares (NQ:QURE)

23.46 +0.09 (+0.39%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about uniQure N.V. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
UNIQURE N.V. (QURE) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds uniQure N.V. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QURE
From SkyMedia, LLC
Via GlobeNewswire
News headline image
uniQure N.V. (QURE) Investors: April 13, 2026, Deadline in Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
uniQure N.V. (QURE) Investors: April 13, 2026, Deadline in Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP
Did you buy QURE ordinary shares between September 24, 2025, and October 31, 2025? 
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QURE
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
QURE Stock Edges Up After Hours As Analyst Flags Reduced Regulatory Uncertainty Following Prasad’s FDA Exit ↗
Mizuho said that Dr. Vinay Prasad’s exit just days after a highly public dispute with uniQure appeared to signal an administration-level desire to restore greater regulatory flexibility in rare disease... 
Via Stocktwits
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming Deadlines – QURE
From Pomerantz LLP
Via GlobeNewswire
News headline image
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against uniQure N.V.
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
QURE Stock’s Relentless Rally Continues Today — Here's Why HC Wainwright Is Bullish On uniQure ↗
H.C. Wainwright stated that the reported departure of a key U.S. Food and Drug Administration official at the end of April bodes well for uniQure. 
Via Stocktwits
Topics Initial Public Offering
News headline image
uniQure N.V. (QURE) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
uniQure N.V. (QURE) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP
Did you buy QURE ordinary shares between September 24, 2025, and October 31, 2025? 
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
QURE Jumps 20% – Analysts Upgrade Stock On Huntington’s Disease Therapy Update, Retail Eyes $150 ↗
Wells Fargo upgraded uniQure’s stock to ‘Overweight,’ citing a bullish outlook for its gene therapy following reports that Vinay Prasad will leave the U.S. FDA next month. 
Via Stocktwits
News headline image
QURE DEADLINE: Investors of uniQure N.V. (QURE) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on April 13, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
QURE DEADLINE: Investors of uniQure N.V. (QURE) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on April 13, 2026
NEW YORK, NY - March 9, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against uniQure N.V. (“uniQure” or the “Company”) (NASDAQ:QURE) on behalf... 
Via TheNewswire.com
Topics Lawsuit
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
uniQure N.V. (QURE) Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP; April 13, 2026, Lead Plaintiff Deadline
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
uniQure N.V. (QURE) Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP; April 13, 2026, Lead Plaintiff Deadline
Did you buy QURE ordinary shares between September 24, 2025, and October 31, 2025? 
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
Investors of uniQure N.V. (QURE) Seeking Recovery - Contact Kaplan Fox Before Deadline on April 13, 2026
NEW YORK, NY - March 7, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against uniQure N.V. (“uniQure” or the “Company”) (NASDAQ: QURE) on behalf... 
Via NewMediaWire
Topics Lawsuit
News headline image
Investors of uniQure N.V. (QURE) Seeking Recovery - Contact Kaplan Fox Before Deadline on April 13, 2026
NEW YORK, NY - March 7, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against uniQure N.V. (“uniQure” or the “Company”) (NASDAQ: QURE) on behalf... 
Via TheNewswire.com
Topics Lawsuit
News headline image
Biotech Stock QURE Once Tagged ‘Failed Product’ — CEO Sold Shares Days Before Rally ↗
On Friday, the trading volume for uniQure increased from its 2 million shares to roughly 17 million. 
Via Stocktwits
News headline image
UPCOMING DEADLINE: uniQure N.V. (QURE) Securities Fraud Class Action – April 13, 2026 Lead Plaintiff Deadline - Faruqi & Faruqi LLP
From Faruqi & Faruqi LLP
Via GlobeNewswire
Here are the top movers in Friday's session. ↗
Via Chartmill
News headline image
Deadline to Lead in Securities Fraud Lawsuit Against uniQure N.V. (QURE) is April 13, 2026 - Contact Kaplan Fox
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Deadline to Lead in Securities Fraud Lawsuit Against uniQure N.V. (QURE) is April 13, 2026 - Contact Kaplan Fox
NEW YORK, NY - March 6, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against uniQure N.V. (“uniQure” or the “Company”) (NASDAQ: QURE) on behalf... 
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Kaplan Fox Encourages Investors of uniQure N.V. (QURE) to Contact the Firm Before Lead Plaintiff Deadline on April 13, 2026
NEW YORK, NY - March 5, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against uniQure N.V. (“uniQure” or the “Company”) (NASDAQ: QURE) on behalf... 
Via TheNewswire.com
Topics Lawsuit
News headline image
Kaplan Fox Encourages Investors of uniQure N.V. (QURE) to Contact the Firm Before Lead Plaintiff Deadline on April 13, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
uniQure N.V. (QURE) Class Action Lawsuit Seeks Recovery for Investors; April 13, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >